Guide for Authors

Introduction

Types of paper

Contributions falling into the following categories will be considered for publication: [ research articles, reviews, health policy, short communications,editorials, commentaries, letters, perspectives, window for China, bridging Belt and Road countries ].

Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

Before you begin

Before You Begin

For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts. Details can be found here. High similarity papers will be desk rejected.

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

• include a statement on ethics approval and consent (even where the need for approval was waived)

• include the name of the ethics committee that approved the study and the committee's reference number if appropriate

All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.

Consent for publication

If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

Studies in humans and animals

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.

The author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the appropriate institutional committee(s). This statement should contain the date and reference number of the ethical approval(s) obtained. Authors should also include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

The journal will not accept manuscripts that contain data derived from unethically sourced organs or tissue, including from executed prisoners or prisoners of conscience, consistent with recommendations by Global Rights Compliance on Mitigating Human Rights Risks in Transplantation Medicine. For all studies that use human organs or tissues authors must provide sufficient evidence that they were procured in line with WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. The source of the organs or tissues used in clinical research must be transparent and traceable. Authors of manuscripts describing organ transplantation must additionally declare within the manuscript:

1. that autonomous consent free from coercion was obtained from the donor(s) or their next of kin; and

2. that organs/tissues were not sourced from executed prisoners or prisoners of conscience.

All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.

Declaration of interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using https://www.elsevier.com/declaration-of-competing-interests and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More Information https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing/

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article automatically screened by the originality detection service CrossCheck.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop.

Preprints

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Authorship Statement

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following.

Sample CRediT author statement

Zhang San: Conceptualization, Methodology, Software Priya Singh.: Data curation, Writing- Original draft preparation. Wang Wu: Visualization, Investigation. Jan Jansen: Supervision. Ajay Kumar: Software, Validation. Sun Qi: Writing- Reviewing and Editing.

More information can be viewed here.

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

Before the accepted manuscript is published: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

After the accepted manuscript is published: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

Clinical trial results

In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.

Reporting clinical trials

Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure.

Registration of clinical trials

Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.

Copyright

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'. Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

Author rights

This journal is a peer-reviewed, fully open access journal owned by People's Medical Publishing House Co., Ltd. (PMPH), who retains copyright of the overall compiled journal and the compiled issues. For the single article, Authors will transfer copyright to PMPH, KeAi Communications Co., Ltd. and PMPH will be granted non-exclusive publishing and distribution rights.

Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated. Please see https://www.elsevier.com/funding.

Open access

Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. To provide open access, this journal has an open access fee (also known as an Article Processing Charge, APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. The APC for this journal is USD 980, excluding taxes. For all papers submitted before the 31st of December 2024, the APC will be waived for authors. PMPH will pay to make the article open access.

Language and language services

Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit https://webshop.elsevier.com/language-editing/ or our customer support site at https://service.elsevier.com for more information.

Submission

Submission to this journal proceeds totally online. Use the following guidelines to prepare your article. Via the homepage of this journal (https://www.editorialmanager.com/glohj/default.aspx) you will be guided stepwise through the creation and uploading of the various files. The system automatically converts source files to a single Adobe Acrobat PDF version of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail and via the author's homepage, removing the need for a hard-copy paper trail. If you are unable to provide an electronic version, please contact the editorial office prior to submission [e-mail: ghj@pmph.com; telephone: 86-10-59787183].

Additional Information

Tables and figures may be presented with captions within the main body of the manuscript; if so, figures should additionally be uploaded as high resolution files.

Preparation

Peer review

This journal operates a double blind review process. All contributions are sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. For more information on the types of peer review, please visit: https://www.elsevier.com/reviewers/peer-review.

1. All manuscripts would be first reviewed by editorial office. Any papers fail to meet the basic standard of the journal would be desk rejected for reasons like out of scope, ethical conflicts, high similarities, lack of originality, flaws in research design or methods, etc. Then, editorial office would reassign selected papers to editor-in-chief.

2. Editor-in-chief would invite multiple reviewers to review this paper or assign an editorial board member to invite reviewers to review this paper.

3. After at least 2 reviewers give their reviews and comments, Editor-in-chief (or the assigned editor) would provide feedbacks based on review comments to the authors including his own review comments.

4. When author submits the revised manuscript, the assigned editor and editor-in-chief would collaborate to make final decision.

5. For submissions from Editor-in-Chief, Associate Editors, Guest Editor(s), other journal Board members, and authors who have conflicts of interest with them, we ensure that the paper is handled confidentially by a different team member.

6. For submissions to Special Issues, if there are conflicts of interest between the Guest Editor(s) and authors, the submissions will be handled by another Editor from Editorial Board who will manage the peer review process and make the decision whether to accept or reject the paper after peer review.

Use of word processing software

It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier. Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.

To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.

LaTeX

If the LaTeX file is suitable, proofs will be produced without rekeying the text. The article should preferably be written using Elsevier's document class "elsarticle", or alternatively any of the other recognized classes and formats supported in Elsevier's electronic submissions system, for further information see https://www.elsevier.com/authors/policies-and-guidelines/latex-instructions.

The Elsevier "elsarticle" LaTeX style file package (including detailed instructions for LaTeX preparation) can be obtained from the Quickguide: https://www.elsevier.com/latex. It consists of the file: elsarticle.cls, complete user documentation for the class file, bibliographic style files in various styles, and template files for a quick start.

Article structure

This section describes the article structure for this journal.

1. Research article

Subdivision - Numbered Sections Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. The abstract is not included in section numbering. Use this numbering also for internal cross-referencing: do not just refer to "the text". Any subsection may be given a brief heading. Each heading should appear on its own separate line.

Abstract The abstract may follow the structured or unstructured format, as determined by the author of the submission. The objective is to provide a concise overview of the proceeding text.

Introduction State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

Material and methods Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference, and only relevant modifications should be described.

Results Results should be comprehensive but concise.

Discussion This should explore the significance of the results of the work, and should not simply repeat the results. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.

Conclusions The main conclusions of the study may be presented in a short Conclusions section, which may appear alone or form a subsection of a Discussion, or Results and Discussion section.

Appendices If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.

2. Review

Three types of review manuscript are accepted by the GLOHJ. These are:

1. State-of-the-Art Review. This article type is intended to review contemporary topics. Authors of this type of review can discuss global public health topics. The editors encourage, but do not require, the submission of topics that elicit some degree of controversy allowing both sides of the controversial issue to be presented in detail using the latest peer-reviewed evidence available. The review should be comprehensive but appropriately concise and, ideally, should be authored by two or more experts presenting opposing perspectives.

2. Systematic Review. This manuscript type comprehensively evaluates the peer-reviewed literature relating to a specific global health topic. Article selection should be based on clearly defined inclusion and exclusion criteria intended to capture all appropriate articles and to minimize selection bias. These criteria must be described in detail. The literature review must be thorough and should incorporate a careful evaluation of the levels of evidence associated with each of the included articles.

3. Evidence-Based Review (Meta Analyse). This article type represents the highest level of evidence. An Evidence-Based Review incorporates a systematic review and specific global public health recommendations. Upon evaluating the strength of the evidence, authors should use the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) Working Group criteria to classify recommendations as either "Strong" or "Weak". In brief, if the balance of evidence conclusively indicates that a particular intervention will be of benefit to the people, outweighing the risks, then the recommendation can be strong. Similarly, if the evidence conclusively indicates that the risk outweighs the benefit, a strong recommendation for not performing a particular intervention can be made. When the balance of risks and benefits is uncertain or similar, a weak recommendation should be made. Critically, when making recommendations, the authors should discuss the values and preferences that were brought to bear in making the decision, particularly in the context of weak recommendations.

Reviews should be formatted as follows:

• Abstract (300 words) with the following subheadings: Objective, Data Sources, Methods, Results, Conclusion

• Introduction

• Methods (not applicable to State-of-the-Art Review)

• Results (not applicable to State-of-the-Art Review)

• Discussion

• Conclusion

• References

Systematic and Evidence-Based Reviews should follow the formatting guidelines described in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) document (http://www.prisma-statement.org/). The PRISMA checklist, found on the same website, provides a concise reference that should guide manuscript preparation.

Word count:

• 3000 words for State-of-the-Art Review

• 4500 words for Systematic Review and Evidence-Based Review

Figures/Tables should not exceed 5 in total.

3. Short Communications

This section dedicates to short reports of original researches, short papers addressing new ideas, controversial opinions, "Negative" results and much more.

Generally, the text is within 2,000 words with no more than one table, one figure and five references.

4. Letters

Letters provide a forum for readers to comment about articles recently published in the Journal, and they are a place to publish concise articles, such as reports of novel cases.

The text of letters should be a maximum of 1,000 words, with no more than 10 references and one table or figure.

Title page information

• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name.

• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Contact details must be kept up to date by the corresponding author.

• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

Abstract

A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.

Keywords

Authors are invited to submit keywords associated with their paper.

Abbreviations

Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.

Acknowledgements

Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).

Nomenclature and units

Follow internationally accepted rules and conventions: use the international system of units (SI). If other quantities are mentioned, give their equivalent in SI. Authors wishing to present a table of nomenclature should do so on the second page of their manuscript.

Math formulae

Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).

Footnotes

Footnotes should be used for the e-mail address of corresponding author(s).

Artwork

This section describes the artwork for this journal.

Electronic artwork

General points

• Make sure you use uniform lettering and sizing of your original artwork.

• Save text in illustrations as "graphics" or enclose the font.

• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.

• Number the illustrations according to their sequence in the text.

• Use a logical naming convention for your artwork files.

• Provide captions to illustrations separately.

• Produce images near to the desired size of the printed version.

• Submit each figure as a separate file.

A detailed guide on electronic artwork is available on our website:

https://www.elsevier.com/artworkinstructions

You are urged to visit this site; some excerpts from the detailed information are given here.

Formats

Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):

EPS: Vector drawings. Embed the font or save the text as "graphics".

TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.

TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.

TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.

If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply "as is".

Please do not:

• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;

• Supply files that are too low in resolution;

• Submit graphics that are disproportionately large for the content.

Color artwork

Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version.

Figure captions

Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.

Tables

Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.

Tables

Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.

References

This section describes the references for this journal.

Citation in text

Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.

Web references

As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.

Preprint references

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the name of the preprint server, as part of the reference. The preprint DOI should also be provided.

References in a special issue

Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.

Reference management software

This journal has standard templates available in key reference management packages EndNote ( http://www.endnote.com/support/enstyles.asp) and Reference Manager ( http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style which is described below.

Reference style

Please notice that GLOHJ use the citation-order system (citation-sequence system), or we call it “Vancouver” system. Not the name-year system (“Harvard” system). Referencing needs to be in AMA Citation Style via https://www.scribbr.com/category/ama/. All citations in the text should refer to:

1. Format of reference from books: the author's name (last name+ initials of first names). Title of publication. Place of publisher: Name of publisher, the year of publication.

2.Format of reference from journals: the author's name (last name+ initials of first names). Title of publication. Name of the journal. Year;volume(issue):pages.

3. More than six authors: the sixth author's name followed by "et al.".

Citations may be made directly (or parenthetically).

Examples: "More than two decades ago in many developing countries in Asia, the role of the private sector in the healthcare existed more by default than by design [8]."

List: References should be sorted chronologically in text.

Examples:

1. Reference to a journal publication:

[6] Hoang T, Dahlberg SE , Sandler AB , Brahmer JR , Schiller JH , Johnson DH, et al. Prognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumab. J Thorac Oncol. 2012;7(9):1361-8.

2. Reference to a book:

[1] Ben Ramalingam. Aid on the Edge of Chaos: Rethinking International Cooperation in a Complex World. UK: Oxford University Press, 2013.

3. Reference to a chapter in an edited book:

[2] Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW. The genetic basis of human cancer. New York: McGraw-Hill, 2002. 93-113.

Journal abbreviations source

Journal names should be abbreviated according to

Index Medicus journal abbreviations: https://www.nlm.nih.gov/archive/20130415/tsd/serials/lji.html.notice.html;

List of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;

CAS (Chemical Abstracts Service): http://www.cas.org/sent.html.

Submission checklist

The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.

Ensure that the following items are present:

One Author designated as corresponding Author:

• E-mail address

• Full postal address

• Telephone and fax numbers

All necessary files have been uploaded

• Keywords

• All figure captions

• All tables (including title, description, footnotes)

Further considerations

• Manuscript has been "spellchecked" and "grammar-checked"

• References are in the correct format for this journal

• All references mentioned in the Reference list are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Web)

• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print

• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes

For any further information please visit our customer support site at https://service.elsevier.com.

After acceptance

Use of the Digital Object Identifier

The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):

doi:10.1016/j.physletb.2010.09.059

When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.

Post-publication amendments

Errata and Corrigenda

We will publish a correction of your article if a significant error is discovered after publication. An Erratum will be published if we introduced the error; a Corrigendum if the author introduced the error.

Retractions

Articles may be withdrawn, retracted, removed or replaced after publication if they contain substantial errors that cannot be corrected by publishing an Erratum or a Corrigendum, or if ethical violations come to light after publication.

Proofs

One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Global Health Journal now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available free from http://get.adobe.com/reader.

Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:

http://www.adobe.com/products/reader/systemreqs.

If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Global Health Journal in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately - please let us have all your corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.

Author inquiries

Author Inquiries

For inquiries relating to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles at https://www.elsevier.com/trackarticle. You can also check our Author FAQs ( https://www.elsevier.com/authorFAQ) and/or contact Customer Support via https://service.elsevier.com.